PTO Form 1581 (Rev 9/2005) |
OMB No. 0651-0054 (Exp. 10/31/2017) |
Request for Extension of Time to File a Statement of Use
(15 U.S.C. Section 1051(d))
The table below presents the data as entered.
Input Field
|
Entered
|
SERIAL NUMBER |
85647086 |
LAW OFFICE ASSIGNED |
LAW OFFICE 117 |
MARK SECTION |
MARK |
TANDEM (stylized and/or with design) |
STANDARD CHARACTERS |
NO |
USPTO-GENERATED IMAGE |
NO |
OWNER SECTION |
NAME |
CELONOVA BIOSCIENCES, INC. |
STREET |
18615 TUSCANY STONE, SUITE 100 |
CITY |
SAN ANTONIO |
STATE |
Texas |
ZIP/POSTAL CODE |
78258 |
COUNTRY |
United States |
GOODS AND/OR SERVICES SECTION |
INTERNATIONAL CLASS |
010 |
CURRENT IDENTIFICATION |
Medical devices for embolization, namely, syringes and vials filled with embolic microspheres for embolization; Medical devices for
embolization, namely, embolic microspheres for embolization in the form of particles; Medical devices for embolization, namely, embolic microspheres in the form of particles to slow or block blood
flow for mediating devascularizations; Medical devices for embolization, namely, embolic microspheres in the form of particles to block blood flow throughout the vasculature system; Medical devices
for embolization, namely, embolic microspheres in the form of particles to treat hemorrhages, arteriovenous malformations, hemangioendothelioma, cerebral aneurysms, muscle hypertrophy, hypertrophic
cardiomyopathy, gastrointestinal bleeding, trauma, epistaxis, bone cysts, bone metastases, vertebral metastases, varicoceles, congenital hemangioma, artiovenous fistulae, vena cava, vascular
anomalies, priapism, prostatic hematuria, hemoptysis, hemorrhagic cystitis, and post-partum hemorrhage; Medical devices for embolization, namely, embolic microspheres in the form of particles to
prevent or reduce blood flow through any tissue or organ of interest in order to reduce the growths of hypervascular tissues or malignant cells, tumors, lesions, hepatocellular carcinoma, and
fibroids; Medical devices for embolization, namely, embolic microspheres in the form of particles to treat vascular conditions; Medical microspheres for transarterial embolization of tumors,
chemoembolization, transarterial chemoembolization, lesion devascularization, lobe devascularization, and proximal embolization; Medical microspheres for the treatment of hypervascular tumors and
arteriovenous malformations; Medical microspheres for super selective, targeted chemoembolization of a hypervascular tissue or tumor; Drug delivery device, namely, a drug delivery microsphere for
carrying pharmaceuticals or drugs to a precise vasculature bed for localized treatment; Drug delivery device, namely, a drug delivery bead for carrying pharmaceuticals or drugs to a precise
vasculature bed for localized treatment |
GOODS OR SERVICES |
KEEP ALL LISTED |
EXTENSION SECTION |
EXTENSION NUMBER |
2 |
ONGOING EFFORT |
product or service research or development; steps to obtain required governmental approval |
ALLOWANCE MAIL DATE |
07/23/2013 |
STATEMENT OF USE |
NO |
PAYMENT SECTION |
NUMBER OF CLASSES |
1 |
SUBTOTAL AMOUNT |
150 |
TOTAL AMOUNT |
150 |
SIGNATURE SECTION |
SIGNATURE |
/SW/ |
SIGNATORY'S NAME |
Scott D. Woldow |
SIGNATORY'S POSITION |
Attorney of Record, DC bar member |
DATE SIGNED |
07/21/2014 |
SIGNATORY'S PHONE NUMBER |
202-263-4300 |
FILING INFORMATION |
SUBMIT DATE |
Mon Jul 21 16:03:34 EDT 2014 |
TEAS STAMP |
USPTO/ESU-XX.XXX.XXX.XXX-
20140721160334032907-8564
7086-5008576ca77b3a17bc8f
88398947905bba18ac8f95c94
cf51b5aba9c59207aaade-CC-
2712-20140721155956252373 |
PTO Form 1581 (Rev 9/2005) |
OMB No. 0651-0054 (Exp. 10/31/2017) |
SOU Extension Request
(15 U.S.C. Section 1051(d))
To the Commissioner for Trademarks:
MARK: TANDEM (stylized and/or with design)
SERIAL NUMBER: 85647086
The applicant, CELONOVA BIOSCIENCES, INC., having an address of
18615 TUSCANY STONE, SUITE 100
SAN ANTONIO, Texas 78258
United States
requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application. The Notice of Allowance mailing date was 07/23/2013.
For International Class 010:
Current identification: Medical devices for embolization, namely, syringes and vials filled with embolic microspheres for embolization; Medical devices for embolization, namely, embolic microspheres
for embolization in the form of particles; Medical devices for embolization, namely, embolic microspheres in the form of particles to slow or block blood flow for mediating devascularizations;
Medical devices for embolization, namely, embolic microspheres in the form of particles to block blood flow throughout the vasculature system; Medical devices for embolization, namely, embolic
microspheres in the form of particles to treat hemorrhages, arteriovenous malformations, hemangioendothelioma, cerebral aneurysms, muscle hypertrophy, hypertrophic cardiomyopathy, gastrointestinal
bleeding, trauma, epistaxis, bone cysts, bone metastases, vertebral metastases, varicoceles, congenital hemangioma, artiovenous fistulae, vena cava, vascular anomalies, priapism, prostatic hematuria,
hemoptysis, hemorrhagic cystitis, and post-partum hemorrhage; Medical devices for embolization, namely, embolic microspheres in the form of particles to prevent or reduce blood flow through any
tissue or organ of interest in order to reduce the growths of hypervascular tissues or malignant cells, tumors, lesions, hepatocellular carcinoma, and fibroids; Medical devices for embolization,
namely, embolic microspheres in the form of particles to treat vascular conditions; Medical microspheres for transarterial embolization of tumors, chemoembolization, transarterial chemoembolization,
lesion devascularization, lobe devascularization, and proximal embolization; Medical microspheres for the treatment of hypervascular tumors and arteriovenous malformations; Medical microspheres for
super selective, targeted chemoembolization of a hypervascular tissue or tumor; Drug delivery device, namely, a drug delivery microsphere for carrying pharmaceuticals or drugs to a precise
vasculature bed for localized treatment; Drug delivery device, namely, a drug delivery bead for carrying pharmaceuticals or drugs to a precise vasculature bed for localized treatment
For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice
of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate
control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this
specific class.
This is the second extension request. The applicant has made the following ongoing efforts to use the mark in commerce on or in connection with each of those goods/services covered by the extension
request: product or service research or development; steps to obtain required governmental approval
A fee payment in the amount of $150 will be submitted with the form, representing payment for 1 class.
Declaration
STATEMENTS: The signatory believes that: the applicant has a continued bona fide intention to use or use through the applicant's related company or licensee the mark in commerce on or in connection
with all the goods/services under Section 1(b) in the notice of allowance or as subsequently modified; and that to the best of the signatory's knowledge and belief, no other person has the right to
use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services of such other person, to cause confusion or
mistake, or to deceive.
DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. Section 1001, and that such willful false
statements and the like may jeopardize the validity of the application or submission or any resulting registration, declares that all statements made of his/her own knowledge are true and that all
statements made on information and belief are believed to be true.
Signature: /SW/ Date Signed: 07/21/2014
Signatory's Name: Scott D. Woldow
Signatory's Position: Attorney of Record, DC bar member
Signatory's Phone: 202-263-4300
RAM Sale Number: 85647086
RAM Accounting Date: 07/22/2014
Serial Number: 85647086
Internet Transmission Date: Mon Jul 21 16:03:34 EDT 2014
TEAS Stamp: USPTO/ESU-XX.XXX.XXX.XXX-201407211603340
32907-85647086-5008576ca77b3a17bc8f88398
947905bba18ac8f95c94cf51b5aba9c59207aaad
e-CC-2712-20140721155956252373